TickerFactsScreenerDevelopers

UroGen Pharma Ltd. (URGN) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2014: $3.16M2015: $16.28M2016: $16.31M2017: $68.52M2018: $90.09M2019: $180.30M2020: $96.36M2021: $8.41M2022: -$89.36M2023: -$65.21M2024: -$8.80M2025: -$105.47M-$105.47M
2014Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$105.47M-1098.2%
2024-$8.80M+86.5%
2023-$65.21M+27.0%
2022-$89.36M-1162.2%
2021$8.41M-91.3%
2020$96.36M-46.6%
2019$180.30M+100.1%
2018$90.09M+31.5%
2017$68.52M+320.2%
2016$16.31M+0.2%
2015$16.28M+414.7%
2014$3.16M—